e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 88

Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis

David Hodgson; Richard Pebody; Jasmina Panovska‐Griffiths; Marc Baguelin; Katherine E. Atkins · 2020 · BMC Medicine

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: With a suite of promising new RSV prophylactics on the horizon, including long-acting monoclonal antibodies and new vaccines, it is likely that one or more of these will replace the current monoclonal Palivizumab programme. However, choosing the optimal intervention programme will require balancing the costs of the programmes with the health benefits accrued. METHODS: To compare the next generation of RSV prophylactics, we integrated a novel transmission model with an economic analysis. We estimated key epidemiological parameters by calibrating the model to 7 years of historical ep

Abstract by David Hodgson; Richard Pebody; Jasmina Panovska‐Griffiths; Marc Baguelin; Katherine E. Atkins, BMC Medicine (2020) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1186/s12916-020-01802-8